List view / Grid view

Pushpanathan Muthuirulan

 

Lab Automation In-Depth Focus 2018

In this issue: how lab automation has accelerated pharmaceutical research…

16 March 2018 | By

In this issue: how lab automation has accelerated pharmaceutical research by simplifying operations, reducing manual tasks and increasing the efficiency, quality and reproducibility of results.

Flow cytometry – accelerating neuroscience research

Flow cytometry continues to evolve at a fast pace and…

18 September 2017 | By

Flow cytometry continues to evolve at a fast pace and provides neuroscientists with the ability to perform many highly-specialised assays simultaneously. It meets the demands of cutting-edge research in neuroscience that has allowed researchers to isolate particular neural cells from heterogeneous population and catalogue its molecular or physical features...

NGS In-Depth Focus 2017

Next-generation sequencing is a crucial part of the scientist's toolkit.…

12 September 2017 | By

Next-generation sequencing is a crucial part of the scientist's toolkit. This in-depth focus compares the strengths and weaknesses of a range of NGS technologies and examines the benefits and challenges of using it in infectious disease diagnosis...

Drug Target Review – Issue #3 2017

Included in this issue: The importance of industry partnerships; Calcilytics…

6 September 2017 | By

Included in this issue: The importance of industry partnerships; Calcilytics as potential novel therapeutic treatments to halt Alzheimer's disease; Accelerating neuroscience research with flow cytometry...

Next-Generation Sequencing In-Depth Focus 2016

NGS technologies have been employed in a wide range of…

11 December 2016 | By ,

NGS technologies have been employed in a wide range of areas in drug discovery, including drug target identification, biomarker discovery and biopharmaceutics development. Pushpanathan Muthuirulan of the National Institutes of Health gives us an overview of this in his article in our NGS In-Depth Focus. Meanwhile, the possibilities that RNA-Seq…

Flow cytometry: breaking bottlenecks in drug discovery and development

The discovery and development of novel drug candidates is a…

20 September 2016 | By ,

The discovery and development of novel drug candidates is a highly complex, time-consuming and expensive process. Pharmaceutical scientists and clinicians should, therefore, reevaluate and modify the existing standard platforms and increase their uptake of robust advanced technologies such as flow cytometry to overcome the bottlenecks in these processes...

Send this to a friend